Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1978 1
1980 1
1981 2
1982 1
1983 2
1984 2
1987 2
1990 1
1992 2
1995 2
1998 1
2001 1
2002 2
2003 3
2006 2
2008 3
2009 3
2010 2
2012 3
2013 2
2014 2
2015 1
2016 3
2017 2
2018 3
2019 3
2020 3
2021 3
2022 2
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone.
Albin H, Vincon G, Demotes-Mainard F, Begaud B, Bedjaoui A. Albin H, et al. Eur J Clin Pharmacol. 1984;26(2):271-3. doi: 10.1007/BF00630299. Eur J Clin Pharmacol. 1984. PMID: 6723769 Clinical Trial.
Ten fasting subjects received 200 mg cimetidine orally either with water or 11 g aluminium phosphate mixture in a randomized, single dose, two-way cross-over study. Blood samples were taken for 12 h and urine was collected for 24 h. ...There were no significant diff …
Ten fasting subjects received 200 mg cimetidine orally either with water or 11 g aluminium phosphate mixture in a randomized, …
Double-blind randomized, multicenter study comparing aluminium phosphate gel with rantitidine in the short-term treatment of duodenal ulcer.
Parente F, Bianchi Porro G, Canali A, Bensi G. Parente F, et al. Hepatogastroenterology. 1995 Apr;42(2):95-9. Hepatogastroenterology. 1995. PMID: 7672773 Clinical Trial.
The efficacy and safety of aluminium phosphate and ranitidine in the short-term treatment of duodenal ulcer were compared in a multicenter, randomized, double-blind study. ...At the end of the treatment period, 74 out of 113 patients (65%) treated with aluminium …
The efficacy and safety of aluminium phosphate and ranitidine in the short-term treatment of duodenal ulcer were compared in a …
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.
Gray GE, Mngadi K, Lavreys L, Nijs S, Gilbert PB, Hural J, Hyrien O, Juraska M, Luedtke A, Mann P, McElrath MJ, Odhiambo JA, Stieh DJ, van Duijn J, Takalani AN, Willems W, Tapley A, Tomaras GD, Van Hoof J, Schuitemaker H, Swann E, Barouch DH, Kublin JG, Corey L, Pau MG, Buchbinder S, Tomaka F; Imbokodo/HVTN 705/HPX2008 Study Group. Gray GE, et al. Lancet Infect Dis. 2024 Nov;24(11):1201-1212. doi: 10.1016/S1473-3099(24)00358-X. Epub 2024 Jul 19. Lancet Infect Dis. 2024. PMID: 39038477 Free PMC article. Clinical Trial.
The current study aimed to evaluate the efficacy and safety of a heterologous HIV-1 vaccine regimen, consisting of a tetravalent mosaic adenovirus 26-based vaccine (Ad26.Mos4.HIV) and aluminium phosphate-adjuvanted clade C glycoprotein (gp) 140, in young women at ri …
The current study aimed to evaluate the efficacy and safety of a heterologous HIV-1 vaccine regimen, consisting of a tetravalent mosaic aden …
Prevention strategies of esophageal stenosis after endoscopic resection for superficial esophageal cancer: a Bayesian network meta-analysis.
Dong Y, Xu H, Yu W, Liu Z, Zhao G, Zhang Z, Xia Y, Xiao S, Yi Q, Lin Z. Dong Y, et al. Int J Surg. 2025 Mar 1;111(3):2651-2661. doi: 10.1097/JS9.0000000000002241. Int J Surg. 2025. PMID: 39869370 Free PMC article.
Eight interventions were effective in preventing post-ER stenosis: oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA) (OR: 0.02, 95% credible interval [CrI]: 0.00-0.11), polyglycolic acid (PGA) + ST (OR: 0.02, 95% CrI: 0.00-0.23), oral tranilast ( …
Eight interventions were effective in preventing post-ER stenosis: oral hydrocortisone sodium succinate and aluminum phosphate …
Phosphate-binding capacities of calcium and aluminum formulations.
Lau AH, Kuk JM, Franson KL. Lau AH, et al. Int J Artif Organs. 1998 Jan;21(1):19-22. Int J Artif Organs. 1998. PMID: 9554821 Clinical Trial.
Calcium and aluminum phosphate binders are used to treat hyperphosphatemia which is responsible for the development of osteodystrophy commonly seen in patients with end-stage renal disease. ...The effect of formulation types on phosphate binding was evaluated. Calci …
Calcium and aluminum phosphate binders are used to treat hyperphosphatemia which is responsible for the development of osteody …
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.
Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TTV, Le DN, Duong AH, Nguyen VL, Huynh TN, Truong HK, Phan TL, Nguyen TTT, Shih SR, Huang CG, Weng YJ, Hsieh EF, Chang S, Chen C, Tai IC, Huang LM. Nguyen TT, et al. Lancet. 2022 Apr 30;399(10336):1708-1717. doi: 10.1016/S0140-6736(22)00313-0. Epub 2022 Apr 12. Lancet. 2022. PMID: 35427481 Clinical Trial.
We aimed to evaluate the efficacy, safety, and immunogenicity of EV71vac, an aluminium phosphate-adjuvanted inactivated EV71 vaccine in children aged 2-71 months. METHODS: We did a randomised, double-blinded, placebo-controlled, phase 3 trial at five hospitals in Ta …
We aimed to evaluate the efficacy, safety, and immunogenicity of EV71vac, an aluminium phosphate-adjuvanted inactivated EV71 v …
Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
Togashi T, Mitsuya N, Kogawara O, Sumino S, Takanami Y, Sugizaki K. Togashi T, et al. Vaccine. 2016 Aug 31;34(38):4635-4641. doi: 10.1016/j.vaccine.2016.05.050. Epub 2016 Jul 26. Vaccine. 2016. PMID: 27265451 Free article. Clinical Trial.
Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
Ahmadi F, Shamekhi F, Lessan-Pezeshki M, Khatami MR. Ahmadi F, et al. Saudi J Kidney Dis Transpl. 2012 Sep;23(5):934-8. doi: 10.4103/1319-2442.100865. Saudi J Kidney Dis Transpl. 2012. PMID: 22982903 Clinical Trial.
Studies comparing the effects of sevelamer and nicotinic acid, both similar non-calcium and non-aluminum phosphate binders, are not available. In this study, 40 patients on HD with a serum phosphorus level of more than 6 mg/dL were enrolled. ...
Studies comparing the effects of sevelamer and nicotinic acid, both similar non-calcium and non-aluminum phosphate binders, ar …
A controlled field trial of an aluminum phosphate-adsorbed cholera vaccine in Calcutta.
Pal SC, Deb BC, Sen Gupta PG, De SP, Sircar BK, Sen D, Sikdar SN. Pal SC, et al. Bull World Health Organ. 1980;58(5):741-5. Bull World Health Organ. 1980. PMID: 7028299 Free PMC article. Clinical Trial.
A controlled field trial to determine the efficacy of a single dose of an aluminium phosphate-adsorbed cholera vaccine was conducted in Calcutta during 1975-77. An aluminium phosphate-adsorbed tetanus toxoid was used as the placebo. ...
A controlled field trial to determine the efficacy of a single dose of an aluminium phosphate-adsorbed cholera vaccine was con …
58 results